Skin extracellular matrix stimulation following injection of a hyaluronic acid-based dermal filler in a rat model.
Sumit Paliwal, Steven Fagien, Xiaojian Sun, Tyler Holt, Thomas Kim, Christopher K Hee, Dennis Van Epps, Darin J Messina
Index: Plast. Reconstr. Surg. 134(6) , 1224-33, (2014)
Full Text: HTML
Abstract
Hyaluronic acid-based dermal fillers have gained rapid acceptance for treating facial wrinkles and deep tissue folds. Although their space-filling properties are well understood, this study evaluates the cellular and molecular changes in skin, as a secondary effect, following injection of a commercially available, 24-mg/ml, cross-linked hyaluronic acid-based filler (HYC-24L+) in a rodent model.Sprague-Dawley rats, aged 2 to 4 months, were injected intradermally with 20 μl of HYC-24L+ using a linear threading technique and followed to 12 weeks after injection. Untreated skin and saline injection were used as study controls. Enzyme-linked immunosorbent assay and reverse-transcriptase polymerase chain reaction methods were used to investigate changes in the expression of several extracellular matrix proteins and genes over time.HYC-24L+ significantly increased the protein expression levels of collagen types I and III in rat dermal tissue for up to 12 weeks. The ratio of collagen type III to type I protein, however, remained unchanged, suggesting maintenance of collagen homeostasis. A significant increase in dermal elastin after HYC-24L+ injection was also observed. Gene expression analysis confirmed that several genes associated with extracellular matrix production and assembly were also transiently up-regulated, and that these changes temporally preceded those observed at the protein level.In addition to its well-understood space-filling function, as a secondary effect, the authors demonstrate that HYC-24L+ stimulates the production of several extracellular matrix components, including dermal collagen and elastin.
Related Compounds
Related Articles:
2013-01-01
[Bioorg. Khim. 39(1) , 55-60, (2013)]
Elastin-derived peptides are new regulators of insulin resistance development in mice.
2013-11-01
[Diabetes 62(11) , 3807-16, (2013)]
2015-01-01
[Arterioscler. Thromb. Vasc. Biol. 35(1) , 146-54, (2015)]
2014-12-01
[Am. J. Physiol. Lung Cell. Mol. Physiol. 307(11) , L822-8, (2014)]
2014-07-01
[J. Wound Care 23(7) , 355-7, (2014)]